Search

everythinglearnresearchcommunity

for

Search:↓

Adults with classic congenital adrenal hyperplasia value medication that prevents weight gain from glucocorticoids the most.

Some skin conditions, like psoriasis and early-onset baldness, may indicate metabolic syndrome, and others are linked to diabetes risk and cardiovascular issues.

Hair loss may indicate a higher risk of heart disease and other health issues related to metabolism.

Prediabetes may be a risk factor for hair loss.

PCOS understanding and treatment are advancing, requiring continuous updates for better patient management.

Alopecia patients have a higher risk of heart disease.

Skin diseases like psoriasis, lupus, and others can increase heart disease risk due to factors like chronic inflammation and genetic susceptibility.

Healthy lifestyle changes, especially weight loss, can improve symptoms and overall health in people with Polycystic Ovary Syndrome, especially if they are overweight or obese.

High testosterone increases heart disease risk in women with PCOS.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Homoeopathic treatment may help manage polycystic ovarian syndrome.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

The shape and size of the placenta may help predict future health risks for both mother and child.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Men with early balding may have hormonal imbalances similar to women with PCOS and could benefit from similar treatments.

People with vitiligo may have a lower risk of heart disease.

Linagliptin slows down premature aging in certain mice.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Systemic minoxidil is generally safe for older adults, but caution is needed for those with heart risks.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Insulin resistance increases the risk of developing type 2 diabetes and other health issues.

Antioxidants may help improve mitochondrial health and could be used to treat diseases related to cell damage.

Hair loss may indicate higher heart risk and metabolic issues.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

The document concludes that transsexual individuals often experience improved quality of life after transitioning, despite higher risks of psychiatric issues and mortality.